RE:RE:RE:RE:What is the guessI concur. Any calculation I have done indicates fair value at US$65 without buyout premium.
Roller007 wrote: A big percentage of Cxr shares were issued at that price, To cinven and Goldman. Nothing have changed since then except the market sentiment towards roll up pharma. The fundemantels are essentially the same, so why should Cxr accept any less. I own as of today close to 50000 shares and i will vote against any lower offer. Without a buyout This company will regain its Share price as the debt is paid off. it will sell very close to 65 usd. Two months ago i predicted this scenario and a $72 usd price. Soon we will know, very soon